Effect of KMD-3213, an α(1a)-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta

European Journal of Pharmacology

Volumn 315, Issue 1, 1996, Pages 73-79

  Yamagishi, Ryoichi ^a   Akiyama, Katsuyoshi ^a   Nakamura, Shunji ^a   Hora, Masachiyo ^a   Masuda, Naoyuki ^a   Matsuzawa, Akane ^a   Murata, Satoshi ^a   Ujiie, Arao ^a   Kurashina, Yoshikazu ^a   Iizuka, Kinji ^a   Kitazawa, Makio ^a  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

(1a) Adrenoceptor; 1 Adrenoceptor subtype; KMD 3213; Prostate; Thoracic aorta

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; HISTAMINE; ISOPRENALINE; PHENYLEPHRINE; PRAZOSIN; SEROTONIN; SILODOSIN; TAMSULOSIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; GUINEA PIG; HEART ATRIUM CONTRACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RABBIT; SMOOTH MUSCLE CONTRACTION; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; INDOLES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PHENYLEPHRINE; PROSTATE; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SULFONAMIDES;

EID: 0030574237     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00589-4     Document Type: Article

References (32)

1. Arunlakshana, O. and H.O. Schild, 1959, Some quantitative uses of drug antagonists, Br. J. Pharmacol. 14, 48.
2. 1D subtype, Eur. J. Pharmacol. 297, 241.
3. Caine, M., 1986, The present role of alpha-adrenergic blockers in the treatment of benign prostatic hypertrophy, J. Urol. 136, 1.
4. 1-adrenoceptor subtypes in human tissues by competitive RT-PCR analysis, Biochem. Biophys. Res. Commun. 213, 935.
5. 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 288, 201.
6. 1-adrenoceptor classification: sharpening Occam's razor, Trends Pharmacol. Sci. 15, 167.
7. 1C subtype, Mol. Pharmacol. 45, 703.
8. Goetz, A.S., M.W. Lutz, T.J. Rimele and D.L. Saussy, Jr., 1994, Characterization of alpha-1 adrenoceptor subtypes in human and canine prostate membranes, J. Pharmacol. Exp. Ther. 271, 1228.
9. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery, Br. J. Pharmacol. 113, 723.
10. 1-adrenoceptors: consensus update, Pharmacol. Rev. 47, 267.
11. 1C-adrenergic receptor, Biochem. Biophys. Res. Commun. 195. 902.
12. Honda, K. and C. Nakagawa, 1986, Alpha-1 adrenoceptor antagonist effects of the optical isomers of YM-12617 in rabbit lower urinary tract and prostate, J. Pharmacol. Exp. Ther. 239, 512.
13. 1-adrenoceptor subtype mediating contraction of the smooth muscle in the lower urinary tract and prostate of rabbits, Naunyn-Schmiedeberg's Arch. Pharmacol. 330, 16.
14. 1-adrenoceptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 328, 264.
15. Jønlar, M., M. Richmann and R.C. Bruskewitz, 1994, Benign prostatic hyperplasia: current pharmacological treatment, Drugs 47, 66.
16. 1-blocker, YM-12617, in the treatment of benign prostatic hypertrophy. YM617 clinical study group, J. Urol. 144, 908.
17. 1D-adrenoceptor-mediating the contractile response of rat aorta to noradrenaline, Br. J. Pharmacol. 115, 981.
18. 1 adrenoceptor subtypes in the human prostate, J. Urol. 149, 640.
19. 1c-) adrenoceptor subtype, Br. J. Pharmacol. 115, 781.
20. 1c-adrenoceptors are the same subtype, Eur. J. Pharmacol. Mol. Pharmacol. Sect. 290, 49.
21. Price, D.T., D.A. Schwinn, J.W. Lomasney, L.F. Allen, M.G. Caron and R.J. Lefkowitz, 1993, Identification, quantification, and localization of mRNA for three distinct alpha-1 adrenergic receptor subtypes in human prostate, J. Urol. 150, 546.
22. 1-adrenergic receptor subtypes in human tissues: implications for human α-adrenergic physiology, Mol. Pharmacol. 45, 171.
23. 1-adrenoceptors and native tissues, Mol. Pharmacol. 48, 250.
24. 2+ signaling mechanism and plays a different physiological role, Mol. Pharmacol. 38, 725.
25. 1-adrenoceptor antagonists on some vascular smooth muscles and efficacy, Jpn. J. Pharmacol. 42, 237.
26. 1-adrenoceptor mechanisms for phenylephrine and tizanidine in rabbit thoracic aorta and common liliac artery, Can. J. Physiol. Pharmacol. 69, 1819.
27. 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man, Eur. J. Pharmacol. 249, 307.
28. Testa, R., C. Destefani, L. Guarneri, E. Poggesi, I. Simonazzi, C. Taddei and A. Leonardi, 1995, The α1d-adrenoceptor subtype is involved in the noradrenaline-induced contractions of rat aorta, Life Sci. 57, PL159.
29. 1C, Biochem. Biophys. Res. Commun. 201, 1296.
30. Yamada, S., N. Ashizawa, H. Ushijima, K. Nakayama, E. Hayashi and K. Honda, 1987, Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy, J. Pharmacol. Exp. Ther. 242. 326.
31. 1-adrenoceptor antagonist binding in human prostate and aorta, Clin. Exp. Pharmacol. Physiol. 21, 405.
32. 1A type, Jpn. J. Pharmacol. 62, 297.